The literature[18] treats breast cancer patients with gemcitabine, which interferes with the expression of VEGF and its receptor in cancer cells by engaging the AKT pathway, thereby promoting apoptosis of tumor cells. This evidence concerns the gene VEGFA and neoplasm.